Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Neisseria meningitidis is a major cause of bacterial septicemia and meningitis. Sequence variation of surface-exposed proteins and cross-reactivity of the serogroup B capsular polysaccharide with human tissues have hampered efforts to develop a successful vaccine. To overcome these obstacles, the en...

Full description

Bibliographic Details
Main Authors: Pizza, M, Scarlato, V, Masignani, V, Giuliani, M, Aricò, B, Comanducci, M, Jennings, G, Baldi, L, Bartolini, E, Capecchi, B, Galeotti, C, Luzzi, E, Manetti, R, Marchetti, E, Mora, M, Nuti, S, Ratti, G, Santini, L, Savino, S, Scarselli, M, Storni, E, Zuo, P, Broeker, M, Hundt, E, Knapp, B
Format: Journal article
Language:English
Published: 2000
_version_ 1797085924945821696
author Pizza, M
Scarlato, V
Masignani, V
Giuliani, M
Aricò, B
Comanducci, M
Jennings, G
Baldi, L
Bartolini, E
Capecchi, B
Galeotti, C
Luzzi, E
Manetti, R
Marchetti, E
Mora, M
Nuti, S
Ratti, G
Santini, L
Savino, S
Scarselli, M
Storni, E
Zuo, P
Broeker, M
Hundt, E
Knapp, B
author_facet Pizza, M
Scarlato, V
Masignani, V
Giuliani, M
Aricò, B
Comanducci, M
Jennings, G
Baldi, L
Bartolini, E
Capecchi, B
Galeotti, C
Luzzi, E
Manetti, R
Marchetti, E
Mora, M
Nuti, S
Ratti, G
Santini, L
Savino, S
Scarselli, M
Storni, E
Zuo, P
Broeker, M
Hundt, E
Knapp, B
author_sort Pizza, M
collection OXFORD
description Neisseria meningitidis is a major cause of bacterial septicemia and meningitis. Sequence variation of surface-exposed proteins and cross-reactivity of the serogroup B capsular polysaccharide with human tissues have hampered efforts to develop a successful vaccine. To overcome these obstacles, the entire genome sequence of a virulent serogroup B strain (MC58) was used to identify vaccine candidates. A total of 350 candidate antigens were expressed in Escherichia coli, purified, and used to immunize mice. The sera allowed the identification of proteins that are surface exposed, that are conserved in sequence across a range of strains, and that induce a bactericidal antibody response, a property known to correlate with vaccine efficacy in humans.
first_indexed 2024-03-07T02:14:45Z
format Journal article
id oxford-uuid:a1d7408c-03c1-41a4-b1e2-72254eb14ee0
institution University of Oxford
language English
last_indexed 2024-03-07T02:14:45Z
publishDate 2000
record_format dspace
spelling oxford-uuid:a1d7408c-03c1-41a4-b1e2-72254eb14ee02022-03-27T02:16:06ZIdentification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a1d7408c-03c1-41a4-b1e2-72254eb14ee0EnglishSymplectic Elements at Oxford2000Pizza, MScarlato, VMasignani, VGiuliani, MAricò, BComanducci, MJennings, GBaldi, LBartolini, ECapecchi, BGaleotti, CLuzzi, EManetti, RMarchetti, EMora, MNuti, SRatti, GSantini, LSavino, SScarselli, MStorni, EZuo, PBroeker, MHundt, EKnapp, BNeisseria meningitidis is a major cause of bacterial septicemia and meningitis. Sequence variation of surface-exposed proteins and cross-reactivity of the serogroup B capsular polysaccharide with human tissues have hampered efforts to develop a successful vaccine. To overcome these obstacles, the entire genome sequence of a virulent serogroup B strain (MC58) was used to identify vaccine candidates. A total of 350 candidate antigens were expressed in Escherichia coli, purified, and used to immunize mice. The sera allowed the identification of proteins that are surface exposed, that are conserved in sequence across a range of strains, and that induce a bactericidal antibody response, a property known to correlate with vaccine efficacy in humans.
spellingShingle Pizza, M
Scarlato, V
Masignani, V
Giuliani, M
Aricò, B
Comanducci, M
Jennings, G
Baldi, L
Bartolini, E
Capecchi, B
Galeotti, C
Luzzi, E
Manetti, R
Marchetti, E
Mora, M
Nuti, S
Ratti, G
Santini, L
Savino, S
Scarselli, M
Storni, E
Zuo, P
Broeker, M
Hundt, E
Knapp, B
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
title Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
title_full Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
title_fullStr Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
title_full_unstemmed Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
title_short Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
title_sort identification of vaccine candidates against serogroup b meningococcus by whole genome sequencing
work_keys_str_mv AT pizzam identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT scarlatov identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT masignaniv identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT giulianim identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT aricob identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT comanduccim identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT jenningsg identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT baldil identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT bartolinie identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT capecchib identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT galeottic identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT luzzie identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT manettir identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT marchettie identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT moram identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT nutis identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT rattig identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT santinil identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT savinos identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT scarsellim identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT stornie identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT zuop identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT broekerm identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT hundte identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing
AT knappb identificationofvaccinecandidatesagainstserogroupbmeningococcusbywholegenomesequencing